Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis
Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis
Recruiting · NCT06184659 · Registry updated 2025-07-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Phase 4 | 2025-07-03 | NCT06184659 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Scandinavian Critical Care Trials Group | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rigshospitalet | Copenhagen | Denmark | 4 |
| Rigshospitalet | Copenhagen | Denmark | 84 |